Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Bioanalysis. 2012 Oct;4(20):2457–2469. doi: 10.4155/bio.12.246

Figure 2.

Figure 2

Area under the receiver operating characteristics (ROC) curve (AuROC) for three glycans comparing a blinded validation set of hepatocellular carcinoma (HCC) cases (n = 47) and CLD controls (n = 27). Symbols: as in Figure 1. Reproduced with permission from [39].